Zobrazeno 1 - 2
of 2
pro vyhledávání: '"on behalf of the CARINAE Study Investigators"'
Autor:
Felipe de Arriba de la Fuente, Mercedes Gironella Mesa, Miguel Teodoro Hernández García, Juan Alonso Soler Campos, Susana Herráez Rodríguez, María José Moreno Belmonte, Teresa Regueiro López, Miriam González-Pardo, María Casanova Espinosa, on behalf of the CARINAE Study Investigators
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1272 (2024)
Real-world evidence on the impact of monoclonal antibodies as first-line treatment in Spain is limited. This observational, retrospective and prospective, multicenter, descriptive study included 117 transplant-ineligible newly diagnosed multiple myel
Externí odkaz:
https://doaj.org/article/a93039e76ef142c7b0c2c28ae9aa25dd
Autor:
de Arriba de la Fuente F; Hematology Department, Hospital Universitario Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, 30008 Murcia, Spain., Gironella Mesa M; Hematology Department, Hospital Universitario Vall d'Hebrón, 08035 Barcelona, Spain., Hernández García MT; Hematology Department, Hospital Universitario de Canarias, 38320 La Laguna, Spain., Soler Campos JA; Hematology Department, Hosptial Universitario Parc Taulí, 08208 Barcelona, Spain., Herráez Rodríguez S; Hematology Department, Hospital Universitario Basurto, 48013 Bilbo, Spain., Moreno Belmonte MJ; Hematology Department, Hospital Universitario Virgen de la Arrixaca, 30120 Murcia, Spain., Regueiro López T; Spanish Multiple Myeloma Patient Community (CEMMP), 24560 León, Spain., González-Pardo M; Medical Department, Janssen-Cilag S.A., Johnson & Johnson Company, 28042 Madrid, Spain., Casanova Espinosa M; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, 29603 Marbella, Spain., On Behalf Of The Carinae Study Investigators
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Sep 26; Vol. 17 (10). Date of Electronic Publication: 2024 Sep 26.